Mini Review
The Resurgence of Mucormycosis in the Covid-19 Era – A Review
Amit Bhardwaj1, Kratika Mishra2*, Shivani Bhardwaj3, Anuj Bhardwaj4
1Department of Orthodontics and Dentofacial Orthopaedics, Modern Dental College and Research Centre, Indore, India
2Department of Orthodontics and Dentofacial Orthopaedics, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India
3Department of Prosthodontics, College of Dental Sciences, Rau, Madhya Pradesh, India
4Department of Conservative Dentistry and Endodontics, College of Dental Sciences, India
Kratika Mishra, Department of Orthodontics and Dentofacial Orthopaedics, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India.
Received Date: June 7, 2021; Published Date:June 25, 2021
Abstract
Mucormycosis (MCM) is a life-threatening infection that carries high mortality rates with devastating disease symptoms and diverse clinical manifestations. This article briefly explains clinical manifestations and risk factors and focuses on putative virulence traits associated with mucormycosis, mainly in the group of diabetic ketoacidotic patients, immunocompromised patients. The diagnosis requires the combination of various clinical data and the isolation in culture of the fungus from clinical samples. Treatment of mucormycosis requires a rapid diagnosis, correction of predisposing factors, surgical resection, debridement and appropriate antifungal therapy. The overall rate of mortality of mucormycosis is approximately 40%.
Keywords:Amphotericin B, emerging, Mucorales, mucormycosis, zygomycetes
-
Amit Bhardwaj, Kratika Mishra, Shivani Bhardwaj, Anuj Bhardwaj. The Resurgence of Mucormycosis in the Covid-19 Era – A Review. 3(1): 2021. ACCS.MS.ID.000551.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.